Global antibody production market to reach $13.28 bn by 2021

The global antibody production market is projected to reach $13.28 billion by 2021 from $7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021

d-fb-monoclonal-antibodies

(Photo Courtesy: www.amgenscience.com)

The improved approval rate of therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are driving the overall antibody production market.

The increasing prevalence of infectious diseases and rising demand for protein therapeutics are expected to provide growth opportunities for players operating in this market.

Based on end users, the market is segmented into pharmaceutical and biotechnology companies, research institutes, and diagnostic laboratories.

See Also: India's medical devices market will hit $17.6 bn by 2020

The pharmaceutical and biotechnology companies segment is expected account for the largest share of the antibody production market and is estimated to register the highest CAGR.

 

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X